Skip to content

Perfusion Assessment in Laparoscopic Left Anterior Resection

Open Label Clinical Study to Demonstrate the Utility of Intra-operative Perfusion Assessment Using NIR Fluorescence Angiography With the PINPOINT® Endoscopic Fluorescence Imaging System and to Assess the Impact of PINPOINT on the Surgical Decision Making Process and on Surgical Outcomes in Laparoscopic Left Anterior Resection Procedures

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01560377
Acronym
PILLAR II
Enrollment
147
Registered
2012-03-22
Start date
2012-05-31
Completion date
2013-11-30
Last updated
2018-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer, Crohn's Disease, Diverticulitis, Polyp, Procidentia, Rectal Cancer

Keywords

Laparoscopic low anterior colon resection, Laparoscopic left colectomy, Colectomy, Rectal cancer, Colon cancer, Crohn's Disease, Polyp, Procidentia, Diverticulitis

Brief summary

The purpose of this study is to demonstrate that NIR fluorescence angiography using the PINPOINT Endoscopic Fluorescence Imaging System (PINPOINT System or PINPOINT) can assess viability of colon tissue during laparoscopic left colectomy. This information will provide the surgeon with clinically relevant information in assessing whether or not the tissue has adequate blood supply in the lower section of the colon prior to a colectomy.

Detailed description

Colectomy is a surgical procedure in which a part or all of the colon is removed. It is used to treat a variety of diseases including colon cancer, diverticulitis, inflammatory bowel disease (including ulcerative colitis or Crohn's disease) and infarcted bowel. This study is the second phase of a three phase process to demonstrate the clinical utility of perfusion assessment by NIR fluorescence angiography in colectomy. The initial phase (Phase I) consisted of a number of small investigative studies that have now been completed. Upon successful completion of this study, it is anticipated that a prospective, multi center, randomized trial will be conducted (Phase III). Information learned from this present study will help guide the design of the randomized trial e.g. specific patient populations that may best benefit from this imaging modality and how randomization should be conducted (e.g. imaged cohort vs. non imaged, or all subjects imaged but then randomized to no image assessment in one arm of the study).

Interventions

The PINPOINT system will be used to provide real-time endoscopic visible and endoscopic NIR fluorescence imaging. PINPOINT enables surgeons to perform routine visible light endoscopic procedures as well as further visually assess vessels, blood flow and related tissue perfusion with near infra-red imaging during minimally invasive surgery

Sponsors

Novadaq Technologies ULC, now a part of Stryker
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is scheduled for laparoscopic left colectomy in the lower region (planned anastomosis located 5 - 15 cm from anal verge) * A negative pregnancy test for women of childbearing potential prior to surgery

Exclusion criteria

* Subject has a previous history of adverse reaction or known allergy to ICG, iodine or iodine dyes * Subject has any medical condition, which in the judgment of the Investigator and/or designee makes the subject a poor candidate for the investigational procedure * Subject is a pregnant or lactating female

Design outcomes

Primary

MeasureTime frameDescription
PINPOINT System Utility in Left Colectomy SurgeryDay of Operation - Day 1To demonstrate the utility of intra-operative assessment of colon perfusion, using the PINPOINT System to optimize the location at which to transect the colon in laparoscopic left colectomies and to assess mucosal perfusion of the completed anastomosis following proximal anastomosis in laparoscopic left colectomy.

Secondary

MeasureTime frameDescription
Safety of the PINPOINT SystemThrough hospital discharge or at 30 days post procedure, whichever is laterTo assess safety related outcomes of the laparoscopic left colectomies with intra-operative assessment of perfusion using the PINPOINT Endoscopic Fluorescence Imaging System for guidance.

Countries

United States

Participant flow

Recruitment details

A total of 147 patients were enrolled, of whom 139 were eligible for analysis. Patients were enrolled at 11 centers in the United States.

Participants by arm

ArmCount
Subjects Imaged With PINPOINT
Colonic tissue perfusion assessed with PINPOINT for laparoscopic left colectomy in the lower tract. PINPOINT Endoscopic Fluorescence Imaging System: The PINPOINT system will be used to provide real-time endoscopic visible and endoscopic NIR fluorescence imaging. PINPOINT enables surgeons to perform routine visible light endoscopic procedures as well as further visually assess vessels, blood flow and related tissue perfusion with near infra-red imaging during minimally invasive surgery
139
Total139

Baseline characteristics

CharacteristicSubjects Imaged With PINPOINT
Age, Continuous58 years
ASA Classification (American Society of Anesthesiologists)
III (patient with severe systemic disease)
46 Participants
ASA Classification (American Society of Anesthesiologists)
II (patient with mild systemic disease)
73 Participants
ASA Classification (American Society of Anesthesiologists)
I (normal healthy patient)
17 Participants
ASA Classification (American Society of Anesthesiologists)
IV (severe life threating systemic disease)
3 Participants
BMI
BMI < 30 kg/m^2
97 Participants
BMI
BMI > 30 kg/m^2
42 Participants
Diagnosis
Colon cancer
29 Participants
Diagnosis
Colovesical fistula
1 Participants
Diagnosis
Crohn's disease
1 Participants
Diagnosis
Diverticulitis
61 Participants
Diagnosis
Polyp
6 Participants
Diagnosis
Procidentia
4 Participants
Diagnosis
Radiation stricture
1 Participants
Diagnosis
Rectal cancer
35 Participants
Diagnosis
Sigmoid volvulus
1 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
10 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
129 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Preoperative chemotherapy
No
126 Participants
Preoperative chemotherapy
Yes
13 Participants
Preoperative radiation therapy
No
124 Participants
Preoperative radiation therapy
Yes
15 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
14 Participants
Race (NIH/OMB)
Black or African American
7 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
12 Participants
Race (NIH/OMB)
White
106 Participants
Region of Enrollment
United States
139 participants
Sex: Female, Male
Female
65 Participants
Sex: Female, Male
Male
74 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 139
serious
Total, serious adverse events
23 / 139

Outcome results

Primary

PINPOINT System Utility in Left Colectomy Surgery

To demonstrate the utility of intra-operative assessment of colon perfusion, using the PINPOINT System to optimize the location at which to transect the colon in laparoscopic left colectomies and to assess mucosal perfusion of the completed anastomosis following proximal anastomosis in laparoscopic left colectomy.

Time frame: Day of Operation - Day 1

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Subjects Imaged With PINPOINTPINPOINT System Utility in Left Colectomy SurgeryChange to surgical plan due to Fluorescence11 Participants
Subjects Imaged With PINPOINTPINPOINT System Utility in Left Colectomy SurgeryNo change to surgical plan due to Fluorescence128 Participants
Secondary

Safety of the PINPOINT System

To assess safety related outcomes of the laparoscopic left colectomies with intra-operative assessment of perfusion using the PINPOINT Endoscopic Fluorescence Imaging System for guidance.

Time frame: Through hospital discharge or at 30 days post procedure, whichever is later

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Subjects Imaged With PINPOINTSafety of the PINPOINT SystemNo major post-operative clinical complication125 Participants
Subjects Imaged With PINPOINTSafety of the PINPOINT SystemClinical anastomotic leak & confirmed by radiology2 Participants
Subjects Imaged With PINPOINTSafety of the PINPOINT SystemPost-operative fever7 Participants
Subjects Imaged With PINPOINTSafety of the PINPOINT SystemDelay in return of bowel function5 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026